Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Novartis to Add Warnings to Rasilez Blood-Pressure Drug
Feb. 20, 2012
Novartis AG said it will add a warning to the label for its blood-pressure drug Rasilez in Europe to comply with a request from regulators.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing